Dr. Emelia Benjamin featured on HealthDay

Dr. Emelia Benjamin, Vice Chair for Faculty Development and Diversity for the Department of Medicine, recently led the committee that published a report titled Heart Disease and Stroke Statistics - 2019 Update, the findings from which were highlighted in a Jan 31st article on HealthDay.com.

While the report found that nearly half of American adults have high blood pressure, heart disease or a history of stroke, there are steps you can take to delay or prevent these conditions. "Stop smoking, eat healthier, exercise, get your cholesterol and blood sugar under control," Benjamin said.

Read More.

Dr. Angela Jackson Receives 2018 Jerome Klein Award

Angela Jackson, MD, associate dean of student affairs, has been named the 2018 recipient of the Jerome Klein Award for Physician Excellence. Dr. Jackson, an associate professor of medicine, also serves as a general internal medicine physician at Boston Medical Center (BMC).

Dr. Jackson is recognized for the Jerome Klein award for her unwavering commitment to our patients and mission, her leadership in the medical community locally to nationally and her profound impact on education and mentorship throughout her 30 years on the medical campus.  Read More.

DOM Faculty Named 2019 Top Docs

Congratulations to the 57 Department of Medicine faculty members who were named to Boston Magazine's annual Top Doc's list!

Allergy & Immunology 
Helen M. Hollingsworth

Cardiac Electrophysiology
Robert H. Helm
Kevin M. Monahan

Cardiovascular Disease
Eric H. Awtry
Gary J. Balady
Sheilah A. Bernard
Robert T. Eberhardt
Alice K. Jacobs

Clinical Genetics
Jodi D. Hoffman

Endocrinology, Diabetes & Metabolism
Sonia Ananthakrishnan
Alan P. Farwell
Michael F. Holick
Stephanie L. Lee
Elizabeth N. Pearce

stroenterology
Charles M. Bliss Jr
Francis A. Farraye
David R. Lichtenstein
Robert C. Lowe
David P. Nunes
Paul C. Schroy III

Geriatric Medicine
Heidi P. Auerbach
Lisa B. Caruso
Hollis D. Day
Eric J. Hardt
Sharon A. Levine 

Hematology
Vaishali H. Sanchorawala   

Internal Medicine
Thomas W. Barber
Melissa D. DiPetrillo
Warren Y. Hershman
Angela H. Jackson
Susan L. Phillips
Jeffrey H. Samet
Charles P. Tifft                     

Interventional Cardiology
Claudia P. Hochberg
Anthony D. Litvak
Ashvin N. Pande 

Medical Oncology
Timothy P. Cooley
Gretchen Gignac
Kevan L. Hartshorn
Matthew H. Kulke
Adam Lerner

Nephrology
Laurence H. Beck Jr
Jasvinder S. Bhatia
David J. Salant   

Pulmonary Disease              
John L. Berk
Jeffrey S. Berman
John Bernardo
Elizabeth S. Klings                          
Frederic F. Little
George T. O'Connor Jr
Arthur C. Theodore

Reproductive Endocrinology
Wendy Kuohung
Robert M. Weiss

Rheumatology
David T. Felson
Eugene Y. Kissin   
Robert W. Simms

Dr. Tuhina Neogi is new Chief of Rheumatology

We are delighted to announce that Tuhina Neogi, M.D., Ph.D., Professor, Department of Medicine, has accepted our offer to become Chief of the Rheumatology Section effective January 1, 2019. Dr. Neogi received her M.D. from the University of Toronto and Ph.D. from the Boston University School of Public Health. She leads an internationally known research team focused on knee osteoarthritis and gout, pain mechanisms in osteoarthritis, and methodologic issues in rheumatic diseases. She has served on a number of national and international committees and organizations, including guideline writing and FDA committees. Her work has been continuously supported by both NIH and national foundations. She is a past recipient of the prestigious Henry Kunkel Young Investigator Award from the American College of Rheumatology and the Robert Dawson Evans Research Mentoring Award from the Department of Medicine. She is also leading the CTSI’s Research Career Support Program. Dr. Neogi is an exceptional investigator, clinician, mentor, and role model. We are thrilled that she has so enthusiastically embraced this critically important leadership opportunity for our department and look forward to working with her.

As part of our strategy to further enhance the clinical and academic programs in Rheumatology, the Sections of Rheumatology and Clinical Epidemiology will be administratively and programmatically re-unified starting January 1, 2019. I would like to express my gratitude to Drs. Robert Simms (Chief, Rheumatology Section) and David Felson (Chief, Clinical Epidemiology Section) for their thoughtful and generous support of the consolidation of the two sections. Their selfless approach to building rheumatology through the consolidation under Dr. Neogi’s leadership has been both remarkable and admirable. Dr. Simms will be appointed an Evans Scholar and will be further building the Scleroderma Program. Dr. Felson will be assuming a more prominent leadership position within the Clinical and Translational Science Institute and continue to expand his very prominent research program. We are very grateful to Drs. Simms and Felson for their many years of service to the department and look forward to working with them in their new roles.

Reducing Readmissions for Patients with Heart Failure and COPD

While BMC’s all cause 30-day readmission rate was 10.96% in FY17, certain populations had much higher readmission rates particularly heart failure (HF) (23.73% FY17) and COPD (24.81% FY17).

With almost 1 in 5 HF and COPD patients readmitted, reducing readmissions for these patients has become an important hospital and quality priority.

Multidisciplinary pilots focusing on transitions of care started on 7/5/18 on E7N for patients with HF, with full go-live anticipated by February 2019.  Menino 6 is piloting similar strategies for patients with COPD.  Both pilots include:

  • Adoption of “Teach Back” methodology for all patient teaching
  • Partnering with home care providers such as our VNAs for home med reconciliation

Unique to HF:

  • HF consult triggers for patients on non-cardiology teams
  • Standardization of patient instructions in AVS using smart phases for HF
  • Facilitated early discharge transitions of care (TCM) appointments
  • Personalized reminder calls by Cardiology Clinic staff one day before post discharge appointments for patients with HF

Unique to COPD:

  • Inpatient COPD NP consult with follow up outpatient appointment. Welcome Alexis Gallardo Foreman, NP to the COPD care team!  Alexis is available to see patients with COPD in both the inpatient and ambulatory settings.

During the 8-week HF pilot on E7N, the 30d readmission rate decreased from 21.6% to 12.9%., with most reduction seen in the 7-10d readmission rate.  In Jan-Nov 2018, COPD readmission rate was 20.7%.

You are the critical link to connecting our patients with HF and COPD to these proven strategies for reducing readmission and improving health.  Please consult the HF or the COPD service to activate patient care resources!

 

Resident QI Corner – Winter ’19

Managing discharge from Inpatient Heme/Onc Service

The inpatient Hematology/Oncology team at BMC is a busy service full of patients with complex medical problems and diverse pathologies requiring intricate care plans. Thus, discharges from the Heme/Onc inpatient service are complicated and are often derailed by unforeseen variables.

We sought to increase the safety and timeliness of discharges by implementing a standardized approach to discharge planning starting on the day of admission. We designed a discharge time-out checklist for the Heme/Onc team.   The team can run the checklist prior to a patient being discharged to ensure all important aspects are addressed. A Heme/Onc Bundle was also created to be used with each daily note to keep up to date on discharge planning.

We implemented the checklists as SmartPhrases from November 2017 to February 2018 and compared to pre-intervention data over the same months from 2016- 2017. After our intervention implementation, discharge time of day on the service improved by 13 minutes and time of discharge order placement  improved by 39 minutes. On average, the Heme/Onc bundle was used in 86% of notes. Future directions include use of a standardized discharge summary template for the Heme/Onc service to help facilitate safe transitions of care.

By  Rani Chudasama, MD and Matt Strickland, MD

                              

IHI Conference 2018 - Dec 9 - 12 

Quality Improvement Patient Safety (QIPS) pathway IM residents attending IHI 2018 National Forum:

Swetha Ramachandran, MD  - Improving Inter-Hospital Transfers Through Implementation of a Transfer Accept Note

 

 

Calan Sowa , MD & Ruchika Sangani, MD - Improving Primary Care Follow-Up through In-Person, In-Hospital Appointment Negotiation

 

 

Nancy Desai, MD - Cervical Cancer Screening and Prevention in Patients with Systemic Lupus Erythematosus

 

 

Kristin Hlebowitsh , MD - Minimizing Isolation: Re-screening inpatients for MRSA infection

 

 

Vishal Gupta , MD- Where Are the Blood Cultures that I Ordered?

 

 

 

Kris Clark, MD and Shaleen Chakyayil , MD - EMR-Based Intervention to Improve Venous Thromboembolism (VTE) Risk Assessment and Prescribing Practices

 

 

Other QIPS residents in attendance:
Mangwe Sabtala, MD
Prianka Ballal, MD
Laura Chiu, MD
Olivia Rowse, MD

For those of us attending for the first time, we got our batteries charged! We look forward to continuing to bring positive change to our patients and to our community.

Reducing Catheter Associated Urinary Tract Infections (CAUTI)

The CAUTI rate on the wards and ICUs for FY18 YTD was 25 infections with a goal of ZERO (FY17, there were 25 infections).

Please only place indwelling urinary catheters for:

  • Hourly urine output monitoring (only in the ICUs)
  • Management of urinary retention, and
  • Assistance in healing a stage 3 or 4 pressure ulcer

If a patient has a fever with a Foley catheter in place, DO NO SEND BOTH A URINALYSIS AND A URINE CULTURE TOGETHER!  First send a urinalysis (UA).  If the UA is positive (greater than 10 WBC, presence of bacteria as shown by bacteria on microscope slide, positive leukocyte esterase, or positive nitrates), have the nurse change the Foley catheter and then send a urine culture.  This helps greatly reduce false positive urine cultures which are then labeled as CAUTIs.  There is now a BPA which fires as a reminder to adhere to this process.

Always remove Foley catheters as soon as they are no longer needed; review need for placement as DAILY rounds and Multidisciplinary Rounds.

 

 

Reducing Clostridium Difficile Infections

One major component of preventable harm is hospital-acquired C. difficile infections.  Due to the ongoing work of Deb Gregson and the QI team, we have made considerable progress.  BMC is above goal with FY18 Standardized Infection Ratio (SIR) of 0.97 (goal ≤0.7).

Key drivers for reducing C diff. are decreasing unnecessary testing, ensuring timely isolation/contact precaution adherence, antibiotic stewardship, and washing hands with soap and water.  Ways to help:

  • Do not send C diff. test unless > 3 loose or watery stools in a 24 hour period.
  • Do not retest within 7 days of a previous negative, within 30 days of a previous positive C diff. test result, or if the patient has had a positive result within the current admission (prior results will be made available when order placed).
  • No need to test for cure
  • BPA will alert you if the patient has received laxatives in past 48 hours.
  • If you have a suspicion for C diff., place Contact PLUS Isolation Precautions which is part of the C diff. test order.
  • Whenever you enter a patient’s room on Contact PLUS, Wash in, Gown up, Glove up. Dispose of dress in room and SOAP OUT.
  • Discontinue precautions if test is negative.
  • Use oral vancomycin as first line treatment for C diff. (thought to have more rapid response than metronidazole and reduce contagion more quickly.)

 

2018 BACO MassHealth PC Group Quality Bonus Program

Starting in 2018, MA Executive Office for Health and Human Services will generate a Quality Score for each ACO participating in the new MassHealth ACO program.  This Quality Score will determine our ACOs share of any surplus or deficit accrued.  The amount of surplus or deficit will be based on the difference between our ACO’s state-assigned spending budget and the actual total cost of care for the patients attributed to BACO.

The state’s Quality Score will be based on both claims-based data and our submission to MassHealth of chart-based information.  In Performance Year 1 (2018), to receive a quality score of 100%, our ACO is only required to submit all requested data (referred to as “pay for reporting”).  Beginning in 2019, our score will be based on our performance on the various metrics, making it essential that BACO begins to build infrastructure across the ACO to enable optimal metric performance.

The amount of the Primary Care Group Quality Bonus, tied to $2 per member per month, awarded to each group will be determined by the group’s performance in three distinct areas:

  1. Complete submission of requested MassHealth beneficiary clinical data to BACO to enable successful BACO pay for reporting in 2018.
  2. Performance by the group on a BACO-created Ambulatory Visit Quality Metric, which is success in maximizing the number of BACO patients seen in the ambulatory setting. Only 60% of BACO patients were seen between 3/1/17 and 12/31/17.
  3. Performance by the group in the BACO-created Diagnosis Identification Program Screening for homelessness and depression which can be performed by any office staff. Based upon historical performance, that screening rates of 80% are feasible for both homelessness and depression.  The bonus, however, will be based upon each group’s performance normalized to the BACK mean performance rate.  Screening for homelessness should be done as part of a larger social determinants of health screen using a screening tool such as THRIVE.  Screening for depression should be done with a screening tool such as PHQ2 or 9.  Groups should make every effort to capture an appropriate diagnosis code with appropriate documentation in the medical record whenever a screen yields a diagnosis (e.g. homeless or major depressive disorder).  Groups should also ensure that positive screens are addressed by clinical providers during the encounter to ensure appropriate care of patients.

If you would like more details about the BACO MassHealth Primary Care Group Quality Bonus or any of the metrics, please contact Dr. Brian Jacobson at brian.jacobson@bmc.org.